Were Hedge Funds Right About Matson, Inc. (MATX)?

In This Article:

"I have been following Dr. Inan Dogan since this outbreak, and he is a phenomenally intelligent researcher. One month ago, Dr. Dogan's prediction that the total U.S. death toll would be 20,000+ by April 15th was deemed "radical". His Recession is Imminent article in February was very timely. Now he believes we could quickly end lockdowns in NYC after some simple testing. A must read" were the words used by our readers to describe our latest article.

In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out what the billionaire investors and hedge funds think of Matson, Inc. (NYSE:MATX).

Matson, Inc. (NYSE:MATX) shares haven't seen a lot of action during the fourth quarter. Overall, hedge fund sentiment was unchanged. The stock was in 10 hedge funds' portfolios at the end of the fourth quarter of 2019. At the end of this article we will also compare MATX to other stocks including IAMGOLD Corporation (NYSE:IAG), Fitbit Inc (NYSE:FIT), and Central Garden & Pet Co (NASDAQ:CENT) to get a better sense of its popularity.

To most shareholders, hedge funds are viewed as slow, old financial vehicles of years past. While there are more than 8000 funds trading today, We look at the aristocrats of this club, approximately 850 funds. These hedge fund managers shepherd the majority of the smart money's total capital, and by monitoring their best picks, Insider Monkey has deciphered a number of investment strategies that have historically outrun Mr. Market. Insider Monkey's flagship short hedge fund strategy exceeded the S&P 500 short ETFs by around 20 percentage points per year since its inception in March 2017. Our portfolio of short stocks lost 35.3% since February 2017 (through March 3rd) even though the market was up more than 35% during the same period. We just shared a list of 7 short targets in our latest quarterly update .

[caption id="attachment_758454" align="aligncenter" width="399"]

James Dondero Highland Capital Management
James Dondero Highland Capital Management

James Dondero of Highland Capital Management[/caption]

We leave no stone unturned when looking for the next great investment idea. For example, Federal Reserve and other Central Banks are tripping over each other to print more money. As a result, we believe gold stocks will outperform fixed income ETFs in the long-term. So we are checking out investment opportunities like this one. We are probably at the peak of the COVID-19 pandemic, so we check out this biotech investor's coronavirus picks. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences (by the way watch this video if you want to hear one of the best healthcare hedge fund manager's coronavirus analysis). Our best call in 2020 was shorting the market when S&P 500 was trading at 3150 after realizing the coronavirus pandemic's significance before most investors. Now let's take a look at the fresh hedge fund action regarding Matson, Inc. (NYSE:MATX).